Details up front: mazdutide · 10 mg/mL.
I would rather over-plan the first cycle and simplify later.
I am prepared to do the work if someone can tell me which work matters.
What is the minimum version of this that is still defensible?
Details up front: mazdutide · 10 mg/mL.
I would rather over-plan the first cycle and simplify later.
I am prepared to do the work if someone can tell me which work matters.
What is the minimum version of this that is still defensible?
At 10 mg/mL a 0.25 mg dose is 2.5 units on a U-100 barrel and a 1 mg dose is 10 units. Volume is dose divided by concentration and one unit is 0.01 mL, so the unit count is dose ÷ 10 × 100. That puts the smaller dose below five units, where a half-graduation misread is more than ten per cent of the dose — reconstitute to a lower concentration if small doses are the point.
Answer first: diluent volume sets concentration and therefore resolution on the syringe barrel, and resolution is free at reconstitution and impossible to recover afterwards.
Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
To be exact about it, for a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.
Measure a volume you can actually measure. Round numbers, real syringes.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAsk PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.